Balanced Anxiolytic-Beta Blocker Ratio
Each tablet contains Clonazepam 0.25 mg and Propranolol 20 mg with precision content uniformity and consistent dissolution kinetics complying with Indian Pharmacopoeia standards.
DELOTRIL-PRO-0.25 is an advanced fixed-dose combination oral tablet uniting Clonazepam IP 0.25 mg with Propranolol Hydrochloride IP 20 mg by Blessme, the neurology and psychiatry division of Dellwich Lifescience LLP. Specifically designed to control somatic panic storms, public speaking phobias, and stress-induced tremors by combining central limbic calming with robust peripheral beta-adrenergic cardiac protection.

Detailed pharmaceutical specifications, active API monograph compliance, balanced somatic synergy, and blister packaging details for DELOTRIL-PRO-0.25.
DELOTRIL-PRO-0.25 provides 0.25 mg Clonazepam paired with 20 mg Propranolol Hydrochloride. It provides complete protection against the physical sensations of panic (racing pulse, tremors, flushing) while keeping the mind alert and composed.
In-depth pharmacological evaluation of Clonazepam IP 0.25 mg + Propranolol HCl IP 20 mg tablets, marketed as DELOTRIL-PRO-0.25 by Blessme (Dellwich Lifescience LLP). Covers somatic feedback loops, stage fright mitigation, and pharmaceutical supply across India.
DELOTRIL-PRO-0.25 is an optimized dual-action oral tablet that addresses anxiety through two distinct physiological pathways. While psychological anxiety originates in the limbic system, its physical symptoms (tachycardia, diaphoresis, hyperventilation, tremors) are executed through the sympathetic nervous system via beta-adrenergic receptors.
When clinicians search for Clonazepam Propranolol 0.25 20 tablet or tablet for stage fright and palpitations, they require proven content uniformity and reliable release kinetics. DELOTRIL-PRO-0.25 delivers these qualities through automated clean-room manufacturing under WHO-GMP compliance.
Approved neurological and psychiatric indications for DELOTRIL-PRO-0.25 include:
Propranolol 20 mg competitively antagonizes beta-1 and beta-2 adrenergic receptors throughout the cardiovascular and musculoskeletal systems. This effectively prevents catecholamines (epinephrine and norepinephrine) from causing sinus tachycardia, systolic blood pressure spikes, and peripheral muscle tremors.
Simultaneously, Clonazepam 0.25 mg acts as a positive allosteric modulator on the GABAA receptor-chloride ion channel complex. It increases the frequency of channel openings, augmenting chloride influx and hyperpolarizing limbic neurons. By shutting off both the central fear alarm and peripheral bodily panic symptoms, DELOTRIL-PRO-0.25 delivers complete emotional composure.
Clinical criteria for selecting between the formulations:
DELOTRIL-PRO-0.25 must be taken strictly in accordance with medical advice:
DELOTRIL-PRO-0.25 contains Clonazepam, which carries potential for tolerance and habit formation with prolonged therapy. Contraindicated in patients with asthma, COPD, severe bradycardia, or high-degree AV block. Dispensed strictly against a valid medical prescription.
DELOTRIL-PRO-0.25 is manufactured in WHO-GMP certified facilities adhering to Schedule M protocols, ensuring micro-blend homogeneity and maximum packaging stability.
Each tablet contains Clonazepam 0.25 mg and Propranolol 20 mg with precision content uniformity and consistent dissolution kinetics complying with Indian Pharmacopoeia standards.
Sealed in tropicalized blister strips engineered to resist humidity, light exposure, and ambient temperature swings, preserving active potency across all Indian climate zones.
Every batch is backed by authenticated Certificates of Analysis (COA), disintegration profiles, assay validation data, and Material Safety Data Sheets for hospital audits.
Produced in state-of-the-art accredited manufacturing units in Gujarat adhering to automated compression, online check-weighing, and Good Laboratory Practices (GLP).
Prescribing guidance, contraindications, and drug interactions for Clonazepam 0.25 mg + Propranolol 20 mg tablets.
DELOTRIL-PRO-0.25 is a Schedule H prescription drug. Not for OTC sale. Do not consume alcohol during therapy. Exercise caution when driving or operating machinery.
Approved neurological and psychiatric indications for DELOTRIL-PRO-0.25:
Key contraindications and monitoring requirements:
Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-PRO-0.25 (Clonazepam 0.25 mg + Propranolol 20 mg Tablets).
We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.
Whether you are seeking DELOTRIL-PRO-0.25 for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.
Secure district-level monopoly marketing rights for DELOTRIL-PRO-0.25 and the Blessme neuropsychiatry range with visual aids, product glossaries, and promotional input support.
Turnkey manufacturing solutions for pharmaceutical marketing companies with flexible batch runs, rapid production turnaround, and full regulatory dossier support from Ahmedabad.
Direct bulk pharmaceutical supply agreements for multispecialty hospital chains, psychiatric nursing homes, and institutional medical tenders with prompt pan-India logistics.
When sourcing Clonazepam Propranolol tablets in India, DELOTRIL-PRO-0.25 by Blessme provides exceptional clinical efficacy, reliable blister packaging, and comprehensive B2B franchise support.
Manufactured in accredited facilities using IP grade APIs, ensuring exact active content uniformity and fast disintegration.
Tamper-evident, moisture-resistant blister strips protect tablets from ambient humidity and transport friction.
Direct factory dispatch with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.
Exclusive district-level franchise rights for DELOTRIL-PRO-0.25 and the Blessme portfolio with promotional visual aids.
Certificates of Analysis (COA), stability testing data, and MSDS readily available for institutional audits and tenders.
Direct access to Dellwich Lifescience product specialists for quick quotes, customized bulk orders, and customer assistance.
Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam + Propranolol tablets.
DELOTRIL-PRO-0.25 is prescribed for the treatment of anxiety disorders accompanied by marked physical symptoms such as palpitations, elevated pulse, hand tremors, and sweating. It is particularly effective for performance anxiety, social phobia, and acute situational stress.
Each compressed tablet contains Clonazepam IP 0.25 mg and Propranolol Hydrochloride IP 20 mg.
Propranolol is a beta-blocker that stops the autonomic response to stress by blocking adrenaline receptors. This prevents the heart from beating excessively fast, eliminates involuntary muscle shaking, and eliminates cold sweats, thereby removing the physical trigger of anxiety.
Clinicians usually recommend taking one tablet approximately 45 to 60 minutes before the stressful event, ensuring maximum plasma concentration of both active ingredients during peak exposure.
Because the Clonazepam dose is calibrated at 0.25 mg (half the standard 0.5 mg dose), most patients experience mental calmness without heavy sedation. However, individual sensitivity varies, and patients should avoid driving until their response is evaluated.
Patients with a history of asthma, COPD, AV heart block, severe low blood pressure, severe bradycardia, or known hypersensitivity to benzodiazepines or beta-blockers must not take this medication.
No. If taken regularly for more than 2 to 3 weeks, discontinuation should be gradual through tapering. Abrupt stoppage may trigger rebound tachycardia, hypertension, and withdrawal anxiety.
The Clonazepam component belongs to the benzodiazepine class and carries potential for psychological and physiological dependence when taken continuously over extended periods. It is designed for short-term symptomatic therapy or targeted situational usage.
Propranolol may mask tachycardia, which is a key warning symptom of hypoglycemia in diabetic patients. Diabetic patients should use this medication with close blood glucose monitoring under physician guidance.
No. Alcohol interacts adversely with both Clonazepam and Propranolol, precipitating severe hypotension, profound drowsiness, respiratory depression, and dizziness.
DELOTRIL-PRO-0.25 contains 0.25 mg Clonazepam + 20 mg Propranolol, which is ideal for mild-to-moderate somatic panic and situational performance stress. DELOTRIL-PRO-0.5 contains 0.5 mg Clonazepam + 20 mg Propranolol, formulated for severe panic disorder and intense psychiatric agitation.
DELOTRIL-PRO-0.25 is supplied in premium 10x10 and 20x10 blister strips sealed with high-barrier foil to protect from heat and moisture degradation across all Indian climate conditions.
You can send an enquiry using the form below or contact our neuropsychiatry business desk via WhatsApp at +91 99099 31992. We verify district availability and provide full monopoly agreement terms.
Manufactured in advanced WHO-GMP certified facilities located in Gujarat, adhering to Indian Pharmacopoeia standards and automated validation procedures.
Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.
Get wholesale pricing, PCD franchise monopoly rights, and technical documentation for Clonazepam 0.25mg + Propranolol 20mg Tablets.